Name: MDGL Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: MDGL, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does MDGL have?

Accepted Answer

MADRIGAL PHARMACEUTICALS, INC. (MDGL) has 39 SEC Form 4 filings (210 transaction rows) in the rolling 365-day window, disclosed by 9 distinct insiders. Most recent filing: Aug 20, 2026.

Question 2

When was the most recent SEC Form 4 filing for MDGL?

Accepted Answer

The most recent Form 4 filing for MDGL on Tracefour is dated Aug 20, 2026.

Question 3

Who is the most active insider at MDGL?

Accepted Answer

The most active SEC Form 4 filer at MDGL in the rolling window is President and CEO Sibold William John, with 5 filings.

Question 4

What is the net insider flow at MDGL over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at MDGL have net sold $8.2M based on SEC Form 4 disclosures.

Question 5

What is the total insider buy and sell value at MDGL in the current window?

Accepted Answer

Inside the rolling window, insiders at MDGL bought $0 and sold $78.5M based on SEC Form 4 filings.

Question 6

Can I get alerts for MDGL insider trading?

Accepted Answer

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at MADRIGAL PHARMACEUTICALS, INC. (MDGL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

						Source
Kelley Shannon TFirst in 6 months	General Counsel	Sale	664	$342K	Aug 20	SEC ↗
Sibold William JohnFirst in 5 months	President and CEO	Sale	2,500	$1.4M	Jul 21	SEC ↗
Soergel David	Chief Medical Officer	Sale	1,042	$517K	Jun 1	SEC ↗
Levy Richard SFirst in 6 months	Director	Sale	5,682	$2.9M	May 22	SEC ↗
Soergel DavidFirst filing	Chief Medical Officer	Sale	844	$435K	May 18	SEC ↗
Dier Mardi	EVP and CFO	Sale	1,982	$854K	Mar 6	SEC ↗
Huntsman Carole	Chief Commercial Officer	Sale	419	$181K	Mar 6	SEC ↗
Kelley Shannon T	General Counsel	Sale	360	$155K	Mar 6	SEC ↗
Sibold William John	President and CEO	Sale	1,663	$718K	Mar 6	SEC ↗
Taub Rebecca	Director	Sale	491	$212K	Mar 6	SEC ↗
Dier Mardi	EVP and CFO	Sale	1,183	$505K	Mar 2	SEC ↗
Huntsman Carole	Chief Commercial Officer	Sale	910	$449K	Jan 26	SEC ↗
Sibold William John	President and CEO	Sale	1,577	$777K	Jan 26	SEC ↗
Taub Rebecca	Director	Sale	647	$319K	Jan 26	SEC ↗
Kelley Shannon TFirst filing	General Counsel	Sale	692	$344K	Jan 20	SEC ↗
Taub Rebecca	Director	Sale	2,238	$1.1M	Jan 20	SEC ↗
FRIEDMAN PAUL A	Director	Sale	24,800	$13.0M	Jan 13	SEC ↗
Taub Rebecca	Director	Sale	18,650	$9.7M	Jan 13	SEC ↗
FRIEDMAN PAUL AFirst filing	Director	Sale	24,800	$13.7M	Dec 12	SEC ↗
Taub RebeccaFirst filing	Director	Sale	18,650	$10.3M	Dec 12	SEC ↗
Sibold William John	President and CEO	Sale	2,400	$1.4M	Dec 4	SEC ↗
Dier MardiFirst filing	EVP and CFO	Sale	4,173	$2.4M	Dec 3	SEC ↗
Huntsman CaroleFirst filing	Chief Commercial Officer	Sale	1,958	$1.1M	Nov 21	SEC ↗
Levy Richard SFirst filing	Director	Sale	8,500	$4.4M	Nov 14	SEC ↗
BATE KENNETHFirst filing	Director	Sale	16,575	$8.0M	Nov 7	SEC ↗
Sibold William JohnFirst filing	President and CEO	Sale	7,279	$3.2M	Sep 9	SEC ↗

MDGL

Related companies